Biogen’s tau targeting Alzheimer’s disease therapy gets FDA Fast Track status
Biogen ( NASDAQ: BIIB) said on Wednesday that the U.S. FDA has granted Fast Track designation to BIIB080, its antisense ...
American Association of Individual Investors3d
Why Theratechnologies Inc.’s (THTX) Stock Is Down 14.84%
Theratechnologies Inc.’s THTX share price has dipped by 14.84%, which has investors questioning if this is right time to buy.
pharmaphorum5d
Ionis, Arrowhead hail data with triglyceride drugs at ACC
At ACC, Ionis reported results from the phase 3 BALANCE trial of its olezarsen candidate in patients with FCS, showing that an 80 mg dose given by monthly subcutaneous injection reduced ...
Medscape5d
Pancreatitis News
Medscape Medical News, April 10, 2024 ACC 2024 Early Olezarsen Results Show 50% Reduction in Triglycerides A drug targeting mRNA essential for APO C-III production provided a 50% reduction in ...
TD Cowen Reaffirms Their Buy Rating on Ionis Pharmaceuticals (IONS)
In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Ionis Pharmaceuticals (IONS – Research Report), with a price ...
Ionis Pharmaceuticals initiated with a Neutral at Redburn Atlantic
Redburn Atlantic analyst Joshua Smith initiated coverage of Ionis Pharmaceuticals (IONS) with a Neutral rating and $39 price target Ionis is a ...
Finanznachrichten3d
Swedish Orphan Biovitrum AB: Sobi publishes Annual and sustainability report for 2024
STOCKHOLM, March 31, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) published its Annual and sustainability report today. The report details the progress Sobi has made in 2024 ...
Yahoo Finance6d
Theratechnologies Inc. (THTX)
New, improved formulation set to replace EGRIFTA SV® MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company ...